Literature DB >> 8156230

Infection in the neutropenic patient: directions for future research.

S C Schimpff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8156230     DOI： 10.1007/bf00366038

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  12 in total

1.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

Authors:  G P Bodey; M Buckley; Y S Sathe; E J Freireich
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

2.  Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia.

Authors:  P A Pizzo; K J Robichaud; F A Gill; F G Witebsky
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

3.  Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.

Authors:  S C Schimpff; H Gaya; J Klastersky; M H Tattersall; S H Zinner
Journal:  J Infect Dis       Date:  1978-01       Impact factor: 5.226

4.  Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

Authors:  S C Schimpff; V M Young; W H Greene; G D Vermeulen; M R Moody; P H Wiernik
Journal:  Ann Intern Med       Date:  1972-11       Impact factor: 25.391

5.  Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia.

Authors:  S Schimpff; W Satterlee; V M Young; A Serpick
Journal:  N Engl J Med       Date:  1971-05-13       Impact factor: 91.245

6.  Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group.

Authors: 
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

7.  Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.

Authors:  J L Shenep; W T Hughes; P K Roberson; K R Blankenship; D K Baker; W H Meyer; F Gigliotti; J W Sixbey; V M Santana; S Feldman
Journal:  N Engl J Med       Date:  1988-10-20       Impact factor: 91.245

8.  A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia.

Authors:  P A Pizzo; J W Hathorn; J Hiemenz; M Browne; J Commers; D Cotton; J Gress; D Longo; D Marshall; J McKnight
Journal:  N Engl J Med       Date:  1986-08-28       Impact factor: 91.245

9.  Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia.

Authors:  Thierry Calandra; J Klastersky; H Gaya; M P Glauser; F Meunier; S H Zinner
Journal:  N Engl J Med       Date:  1987-12-31       Impact factor: 91.245

10.  Antibiotic synergism and response in gram-negative bacteremia in granulocytopenic cancer patients.

Authors:  C A De Jongh; J H Joshi; K A Newman; M R Moody; R Wharton; H C Standiford; S C Schimpff
Journal:  Am J Med       Date:  1986-05-30       Impact factor: 4.965
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.